Model systems and unique biological features of high and low-grade colorectal cancer (CRC) revealed by xenografting 84 human CRC cell lines.

通过对 84 种人类 CRC 细胞系进行异种移植,揭示了高低级别结直肠癌 (CRC) 的模型系统和独特的生物学特征

阅读:5
作者:Luk Ian Y, Mooi Jennifer K, Mouradov Dmitri, Tan Tao, Scott Cameron M, Chionh Fiona, Jenkins Laura J, Reehorst Camilla M, Nightingale Rebecca, Savas Peter, Tse Janson Wt, Crake Rebekah Li, Batlle Eduard, Arango Diego, Dopeso Higino, Gibbs Peter, Tebbutt Niall C, Luwor Rod B, Scott Andrew M, Basheer Faiza, Dhillon Amardeep S, Clemons Nicholas J, Williams David S, Firestein Ron, Sieber Oliver M, Mariadason John M
Colorectal cancers (CRCs) present across a range of differentiation grades, which impact patient outcome and management; however, the molecular features and drivers of differentiation status are not fully understood. To address this, 84 commonly used human CRC cell lines were grown as xenografts in mice, revealing models of low-grade (LG) and high-grade (HG) CRC. Transcriptional profiling revealed coordinate downregulation of multiple transcription factors involved in intestinal development and differentiation, markers of colonic lineage-specific differentiation, and effectors of normal functions of the colonic epithelium in HG tumours. Mechanistically, multiple genes suppressed in HG tumours harboured promoter methylation, indicative of stable epigenetic silencing. Furthermore, markers of LGR5+ colon stem cells were suppressed in HG tumours, while markers of cell proliferation, fetal-like intestinal stem cells, and non-canonical cell types including mesenchymal cells were increased. These changes manifested in HG cell line displaying increased proliferation, migration and metastatic capacity. Importantly, CRC cell line-derived transcriptional profiles of differentiation grade were reflected in LG and HG patient-derived tumour organoids and primary CRCs, revealing cell lines accurately model differentiation grade. The models and tumour differentiation-related properties identified herein may inform new approaches for tailored CRC treatments based on tumour grade.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。